speb/financial-data huggingface dataset:
RSO.DE cash_flow (annual, 2024-01-31) — Purchase Of PPE: -762812000.00
RSO.DE balance_sheet (annual, 2024-01-31) — Receivables: 130766000.00
RSO.DE income_statement (annual, 2024-01-31) — Reconciled Cost Of Revenue: 14801601000.00
RSO.DE income_statement (annual, 2024-01-31) — Reconciled Depreciation: 419432000.00
RSO.DE cash_flow (annual, 2024-01-31) — Repayment Of Debt: 0.00
RSO.DE cash_flow (annual, 2024-01-31) — Repurchase Of Capital Stock: -998564000.00
RSO.DE balance_sheet (annual, 2024-01-31) — Retained Earnings: 3548667000.00
RSO.DE cash_flow (annual, 2024-01-31) — Sale Of PPE: 0.00
RSO.DE income_statement (annual, 2024-01-31) — Selling General And Administration: 3267677000.00
RSO.DE balance_sheet (annual, 2024-01-31) — Share Issued: 335172000.00
RSO.DE cash_flow (annual, 2024-01-31) — Stock Based Compensation: 145490000.00
RSO.DE balance_sheet (annual, 2024-01-31) — Stockholders Equity: 4871326000.00
RSO.DE balance_sheet (annual, 2024-01-31) — Tangible Book Value: 4871326000.00
RSO.DE income_statement (annual, 2024-01-31) — Tax Effect Of Unusual Items: 0.00
RSO.DE income_statement (annual, 2024-01-31) — Tax Provision: 597261000.00
RSO.DE income_statement (annual, 2024-01-31) — Tax Rate For Calcs: 0.24
RSO.DE balance_sheet (annual, 2024-01-31) — Total Assets: 14300109000.00
RSO.DE balance_sheet (annual, 2024-01-31) — Total Capitalization: 7082343000.00
RSO.DE balance_sheet (annual, 2024-01-31) — Total Debt: 5747704000.00
RSO.DE balance_sheet (annual, 2024-01-31) — Total Equity Gross Minority Interest: 4871326000.00
RSO.DE income_statement (annual, 2024-01-31) — Total Expenses: 18069278000.00
RSO.DE balance_sheet (annual, 2024-01-31) — Total Liabilities Net Minority Interest: 9428783000.00
RSO.DE balance_sheet (annual, 2024-01-31) — Total Non Current Assets: 6901971000.00
RSO.DE balance_sheet (annual, 2024-01-31) — Total Non Current Liabilities Net Minority Interest: 5242987000.00
RSO.DE income_statement (annual, 2024-01-31) — Total Operating Income As Reported: 2307663000.00
RSO.DE balance_sheet (annual, 2024-01-31) — Total Tax Payable: 76370000.00
RSO.DE balance_sheet (annual, 2024-01-31) — Tradeand Other Payables Non Current: 56045000.00
RSO.DE balance_sheet (annual, 2024-01-31) — Treasury Stock: 633318000.00
RSO.DE balance_sheet (annual, 2024-01-31) — Working Capital: 3212342000.00
RSO.DE income_statement (annual, 2025-01-31) — +Operating Expense: 3283127000.00
RSO.DE income_statement (quarterly, 2025-01-31) — +Operating Expense: 837633000.00
RSO.DE income_statement (annual, 2025-01-31) — +Total Revenue: 21129219000.00
RSO.DE income_statement (quarterly, 2025-01-31) — +Total Revenue: 5912279000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Accounts Payable: 2126317000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Accounts Payable: 2126317000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Accounts Receivable: 144482000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Accounts Receivable: 144482000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Accumulated Depreciation: -4730733000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Accumulated Depreciation: -4730733000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Additional Paid In Capital: 2097110000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Additional Paid In Capital: 2097110000.00
RSO.DE income_statement (annual, 2025-01-31) — Basic Average Shares: 328593000.00
RSO.DE income_statement (annual, 2025-01-31) — Basic EPS: 6.36
RSO.DE cash_flow (annual, 2025-01-31) — Beginning Cash Position: 4935441000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Beginning Cash Position: 4414658000.00
RSO.DE cash_flow (annual, 2025-01-31) — Capital Expenditure: -720104000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Capital Expenditure: -205982000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Capital Lease Obligations: 3467618000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Capital Lease Obligations: 3467618000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Capital Stock: 3288000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Capital Stock: 3288000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Cash And Cash Equivalents: 4730744000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Cash And Cash Equivalents: 4730744000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Cash Cash Equivalents And Short Term Investments: 4730744000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Cash Cash Equivalents And Short Term Investments: 4730744000.00
RSO.DE cash_flow (annual, 2025-01-31) — Cash Dividends Paid: -488721000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Cash Dividends Paid: -121229000.00
RSO.DE cash_flow (annual, 2025-01-31) — Cash Flow From Continuing Financing Activities: -1858505000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Financing Activities: -377413000.00
RSO.DE cash_flow (annual, 2025-01-31) — Cash Flow From Continuing Investing Activities: -637462000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Investing Activities: -123340000.00
RSO.DE cash_flow (annual, 2025-01-31) — Cash Flow From Continuing Operating Activities: 2356988000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Operating Activities: 882557000.00
RSO.DE cash_flow (annual, 2025-01-31) — Change In Account Payable: 154664000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Change In Account Payable: -235734000.00
RSO.DE cash_flow (annual, 2025-01-31) — Change In Income Tax Payable: -27457000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Change In Income Tax Payable: 36559000.00
RSO.DE cash_flow (annual, 2025-01-31) — Change In Inventory: -252293000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Change In Inventory: 414593000.00
RSO.DE cash_flow (annual, 2025-01-31) — Change In Other Current Assets: -27319000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Change In Other Current Assets: 35474000.00
RSO.DE cash_flow (annual, 2025-01-31) — Change In Other Current Liabilities: -123556000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Change In Other Current Liabilities: -40256000.00
RSO.DE cash_flow (annual, 2025-01-31) — Change In Other Working Capital: 9906000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Change In Other Working Capital: -35000.00
RSO.DE cash_flow (annual, 2025-01-31) — Change In Payable: 127207000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Change In Payable: -199175000.00
RSO.DE cash_flow (annual, 2025-01-31) — Change In Payables And Accrued Expense: 127207000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Change In Payables And Accrued Expense: -199175000.00
RSO.DE cash_flow (annual, 2025-01-31) — Change In Tax Payable: -27457000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Change In Tax Payable: 36559000.00
RSO.DE cash_flow (annual, 2025-01-31) — Change In Working Capital: -266055000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Change In Working Capital: 210601000.00
RSO.DE cash_flow (annual, 2025-01-31) — Changes In Cash: -138979000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Changes In Cash: 381804000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Common Stock: 3288000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Common Stock: 3288000.00
RSO.DE cash_flow (annual, 2025-01-31) — Common Stock Dividend Paid: -488721000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Common Stock Dividend Paid: -121229000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Common Stock Equity: 5509195000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Common Stock Equity: 5509195000.00
RSO.DE cash_flow (annual, 2025-01-31) — Common Stock Payments: -1136071000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Common Stock Payments: -262500000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Construction In Progress: 807256000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Construction In Progress: 807256000.00
RSO.DE income_statement (annual, 2025-01-31) — Cost Of Revenue: 15260506000.00
RSO.DE income_statement (quarterly, 2025-01-31) — Cost Of Revenue: 4343622000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Current Accrued Expenses: 1088774000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Current Accrued Expenses: 1088774000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Current Assets: 7538696000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Current Assets: 7538696000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Current Capital Lease Obligation: 703337000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Current Capital Lease Obligation: 703337000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Current Debt: 699731000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Current Debt: 699731000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Current Debt And Capital Lease Obligation: 1403068000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Current Debt And Capital Lease Obligation: 1403068000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Current Liabilities: 4661825000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Current Liabilities: 4661825000.00
RSO.DE cash_flow (annual, 2025-01-31) — Deferred Income Tax: -9198000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Deferred Income Tax: -9543000.00
RSO.DE cash_flow (annual, 2025-01-31) — Deferred Tax: -9198000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Deferred Tax: -9543000.00
RSO.DE cash_flow (annual, 2025-01-31) — Depreciation Amortization Depletion: 446788000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Depreciation Amortization Depletion: 117204000.00
RSO.DE cash_flow (annual, 2025-01-31) — Depreciation And Amortization: 446788000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Depreciation And Amortization: 117204000.00
RSO.DE income_statement (annual, 2025-01-31) — Diluted Average Shares: 330984000.00
RSO.DE income_statement (annual, 2025-01-31) — Diluted EPS: 6.32
RSO.DE income_statement (annual, 2025-01-31) — Diluted NI Availto Com Stockholders: 2090730000.00
RSO.DE income_statement (quarterly, 2025-01-31) — Diluted NI Availto Com Stockholders: 586784000.00
RSO.DE income_statement (annual, 2025-01-31) — EBIT: 2820541000.00
RSO.DE income_statement (quarterly, 2025-01-31) — EBIT: 784557000.00
RSO.DE income_statement (annual, 2025-01-31) — EBITDA: 3267329000.00
RSO.DE income_statement (quarterly, 2025-01-31) — EBITDA: 901761000.00
RSO.DE cash_flow (annual, 2025-01-31) — End Cash Position: 4796462000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — End Cash Position: 4796462000.00
RSO.DE cash_flow (annual, 2025-01-31) — Financing Cash Flow: -1858505000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Financing Cash Flow: -377413000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Finished Goods: 2444513000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Finished Goods: 2444513000.00
RSO.DE cash_flow (annual, 2025-01-31) — Free Cash Flow: 1636884000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Free Cash Flow: 676575000.00
RSO.DE cash_flow (annual, 2025-01-31) — Gain Loss On Sale Of PPE: -61575000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Gross PPE: 11817994000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Gross PPE: 11817994000.00
RSO.DE income_statement (annual, 2025-01-31) — Gross Profit: 5868713000.00
RSO.DE income_statement (quarterly, 2025-01-31) — Gross Profit: 1568657000.00
RSO.DE cash_flow (annual, 2025-01-31) — Income Tax Paid Supplemental Data: 703079000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Income Tax Paid Supplemental Data: 156966000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Income Tax Payable: 43666000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Income Tax Payable: 43666000.00
RSO.DE income_statement (annual, 2025-01-31) — Interest Expense: 63387000.00
RSO.DE income_statement (quarterly, 2025-01-31) — Interest Expense: 13792000.00
RSO.DE income_statement (annual, 2025-01-31) — Interest Expense Non Operating: 63387000.00
RSO.DE income_statement (quarterly, 2025-01-31) — Interest Expense Non Operating: 13792000.00
RSO.DE income_statement (annual, 2025-01-31) — Interest Income: 234955000.00
RSO.DE income_statement (quarterly, 2025-01-31) — Interest Income: 53533000.00
RSO.DE income_statement (annual, 2025-01-31) — Interest Income Non Operating: 234955000.00
RSO.DE income_statement (quarterly, 2025-01-31) — Interest Income Non Operating: 53533000.00
RSO.DE cash_flow (annual, 2025-01-31) — Interest Paid Supplemental Data: 80316000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Interest Paid Supplemental Data: 0.00
RSO.DE balance_sheet (annual, 2025-01-31) — Inventory: 2444513000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Inventory: 2444513000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Invested Capital: 7724006000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Invested Capital: 7724006000.00
RSO.DE cash_flow (annual, 2025-01-31) — Investing Cash Flow: -637462000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Investing Cash Flow: -123340000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Land And Improvements: 1493496000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Land And Improvements: 1493496000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Leases: 1701340000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Leases: 1701340000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Long Term Capital Lease Obligation: 2764281000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Long Term Capital Lease Obligation: 2764281000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Long Term Debt: 1515080000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Long Term Debt: 1515080000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Long Term Debt And Capital Lease Obligation: 4279361000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Long Term Debt And Capital Lease Obligation: 4279361000.00
RSO.DE cash_flow (annual, 2025-01-31) — Long Term Debt Payments: -250000000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Long Term Debt Payments: 0.00
RSO.DE balance_sheet (annual, 2025-01-31) — Machinery Furniture Equipment: 4521044000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Machinery Furniture Equipment: 4521044000.00
RSO.DE cash_flow (annual, 2025-01-31) — Net Common Stock Issuance: -1136071000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Net Common Stock Issuance: -262500000.00
RSO.DE income_statement (annual, 2025-01-31) — Net Income: 2090730000.00
RSO.DE income_statement (quarterly, 2025-01-31) — Net Income: 586784000.00
RSO.DE income_statement (annual, 2025-01-31) — Net Income Common Stockholders: 2090730000.00
RSO.DE income_statement (quarterly, 2025-01-31) — Net Income Common Stockholders: 586784000.00
RSO.DE income_statement (annual, 2025-01-31) — Net Income Continuous Operations: 2090730000.00
RSO.DE income_statement (quarterly, 2025-01-31) — Net Income Continuous Operations: 586784000.00
RSO.DE income_statement (annual, 2025-01-31) — Net Income From Continuing And Discontinued Operation: 2090730000.00
RSO.DE income_statement (quarterly, 2025-01-31) — Net Income From Continuing And Discontinued Operation: 586784000.00
RSO.DE income_statement (annual, 2025-01-31) — Net Income From Continuing Operation Net Minority Interest: 2090730000.00
RSO.DE income_statement (quarterly, 2025-01-31) — Net Income From Continuing Operation Net Minority Interest: 586784000.00
RSO.DE cash_flow (annual, 2025-01-31) — Net Income From Continuing Operations: 2090730000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Net Income From Continuing Operations: 586784000.00
RSO.DE income_statement (annual, 2025-01-31) — Net Income Including Noncontrolling Interests: 2090730000.00
RSO.DE income_statement (quarterly, 2025-01-31) — Net Income Including Noncontrolling Interests: 586784000.00
RSO.DE income_statement (annual, 2025-01-31) — Net Interest Income: 171568000.00
RSO.DE income_statement (quarterly, 2025-01-31) — Net Interest Income: 39741000.00
RSO.DE cash_flow (annual, 2025-01-31) — Net Issuance Payments Of Debt: -250000000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Net Issuance Payments Of Debt: 0.00
RSO.DE cash_flow (annual, 2025-01-31) — Net Long Term Debt Issuance: -250000000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Net Long Term Debt Issuance: 0.00
RSO.DE income_statement (annual, 2025-01-31) — Net Non Operating Interest Income Expense: 171568000.00
RSO.DE income_statement (quarterly, 2025-01-31) — Net Non Operating Interest Income Expense: 39741000.00
RSO.DE cash_flow (annual, 2025-01-31) — Net Other Financing Charges: -8798000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Net Other Financing Charges: 0.00
RSO.DE balance_sheet (annual, 2025-01-31) — Net PPE: 7087261000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Net PPE: 7087261000.00
RSO.DE cash_flow (annual, 2025-01-31) — Net PPE Purchase And Sale: -637462000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Net PPE Purchase And Sale: -123340000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Net Tangible Assets: 5509195000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Net Tangible Assets: 5509195000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Non Current Deferred Assets: 196786000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Assets: 196786000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Non Current Deferred Liabilities: 383826000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Liabilities: 383826000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Non Current Deferred Taxes Liabilities: 187040000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Taxes Liabilities: 187040000.00
RSO.DE income_statement (annual, 2025-01-31) — Normalized EBITDA: 3267329000.00
RSO.DE income_statement (quarterly, 2025-01-31) — Normalized EBITDA: 901761000.00
RSO.DE income_statement (annual, 2025-01-31) — Normalized Income: 2090730000.00
RSO.DE income_statement (quarterly, 2025-01-31) — Normalized Income: 586784000.00
RSO.DE cash_flow (annual, 2025-01-31) — Operating Cash Flow: 2356988000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Operating Cash Flow: 882557000.00
RSO.DE cash_flow (annual, 2025-01-31) — Operating Gains Losses: -61575000.00
RSO.DE income_statement (annual, 2025-01-31) — Operating Income: 2585586000.00
RSO.DE income_statement (quarterly, 2025-01-31) — Operating Income: 731024000.00
RSO.DE income_statement (annual, 2025-01-31) — Operating Revenue: 21129219000.00
RSO.DE income_statement (quarterly, 2025-01-31) — Operating Revenue: 5912279000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Ordinary Shares Number: 328813000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Ordinary Shares Number: 328813000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Other Current Assets: 218957000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Other Current Assets: 218957000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Other Current Borrowings: 699731000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Other Current Borrowings: 699731000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Other Non Current Assets: 82589000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Other Non Current Assets: 82589000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Other Non Current Liabilities: 9833000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Other Non Current Liabilities: 9833000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Other Properties: 3294858000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Other Properties: 3294858000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Payables: 2169983000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Payables: 2169983000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Payables And Accrued Expenses: 3258757000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Payables And Accrued Expenses: 3258757000.00
RSO.DE income_statement (annual, 2025-01-31) — Pretax Income: 2757154000.00
RSO.DE income_statement (quarterly, 2025-01-31) — Pretax Income: 770765000.00
RSO.DE cash_flow (annual, 2025-01-31) — Proceeds From Stock Option Exercised: 25085000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Proceeds From Stock Option Exercised: 6316000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Properties: 0.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Properties: 0.00
RSO.DE cash_flow (annual, 2025-01-31) — Purchase Of PPE: -720104000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Purchase Of PPE: -205982000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Receivables: 144482000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Receivables: 144482000.00
RSO.DE income_statement (annual, 2025-01-31) — Reconciled Cost Of Revenue: 15260506000.00
RSO.DE income_statement (quarterly, 2025-01-31) — Reconciled Cost Of Revenue: 4343622000.00
RSO.DE income_statement (annual, 2025-01-31) — Reconciled Depreciation: 446788000.00
RSO.DE income_statement (quarterly, 2025-01-31) — Reconciled Depreciation: 117204000.00
RSO.DE cash_flow (annual, 2025-01-31) — Repayment Of Debt: -250000000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Repayment Of Debt: 0.00
RSO.DE cash_flow (annual, 2025-01-31) — Repurchase Of Capital Stock: -1136071000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Repurchase Of Capital Stock: -262500000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Retained Earnings: 4128207000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Retained Earnings: 4128207000.00
RSO.DE cash_flow (annual, 2025-01-31) — Sale Of PPE: 82642000.00
RSO.DE income_statement (annual, 2025-01-31) — Selling General And Administration: 3283127000.00
RSO.DE income_statement (quarterly, 2025-01-31) — Selling General And Administration: 837633000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Share Issued: 328813000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Share Issued: 328813000.00
RSO.DE cash_flow (annual, 2025-01-31) — Stock Based Compensation: 156298000.00
RSO.DE cash_flow (quarterly, 2025-01-31) — Stock Based Compensation: 39086000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Stockholders Equity: 5509195000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Stockholders Equity: 5509195000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Tangible Book Value: 5509195000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Tangible Book Value: 5509195000.00
RSO.DE income_statement (annual, 2025-01-31) — Tax Effect Of Unusual Items: 0.00
RSO.DE income_statement (quarterly, 2025-01-31) — Tax Effect Of Unusual Items: 0.00
RSO.DE income_statement (annual, 2025-01-31) — Tax Provision: 666424000.00
RSO.DE income_statement (quarterly, 2025-01-31) — Tax Provision: 183981000.00
RSO.DE income_statement (annual, 2025-01-31) — Tax Rate For Calcs: 0.24
RSO.DE income_statement (quarterly, 2025-01-31) — Tax Rate For Calcs: 0.24
RSO.DE balance_sheet (annual, 2025-01-31) — Total Assets: 14905332000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Total Assets: 14905332000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Total Capitalization: 7024275000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Total Capitalization: 7024275000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Total Debt: 5682429000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Total Debt: 5682429000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Total Equity Gross Minority Interest: 5509195000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Total Equity Gross Minority Interest: 5509195000.00
RSO.DE income_statement (annual, 2025-01-31) — Total Expenses: 18543633000.00
RSO.DE income_statement (quarterly, 2025-01-31) — Total Expenses: 5181255000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Total Liabilities Net Minority Interest: 9396137000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Total Liabilities Net Minority Interest: 9396137000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Total Non Current Assets: 7366636000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Total Non Current Assets: 7366636000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Total Non Current Liabilities Net Minority Interest: 4734312000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Total Non Current Liabilities Net Minority Interest: 4734312000.00
RSO.DE income_statement (annual, 2025-01-31) — Total Operating Income As Reported: 2585586000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Total Tax Payable: 43666000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Total Tax Payable: 43666000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Tradeand Other Payables Non Current: 61292000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Tradeand Other Payables Non Current: 61292000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Treasury Stock: 719410000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Treasury Stock: 719410000.00
RSO.DE balance_sheet (annual, 2025-01-31) — Working Capital: 2876871000.00
RSO.DE balance_sheet (quarterly, 2025-01-31) — Working Capital: 2876871000.00
RSO.DE income_statement (quarterly, 2025-04-30) — +Operating Expense: 797135000.00
RSO.DE income_statement (quarterly, 2025-04-30) — +Total Revenue: 4984971000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Accounts Payable: 2163954000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Accounts Receivable: 181004000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Accumulated Depreciation: -4812112000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Additional Paid In Capital: 2131533000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Basic Average Shares: 324877000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Basic EPS: 1.48
RSO.DE cash_flow (quarterly, 2025-04-30) — Beginning Cash Position: 4796462000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Capital Expenditure: -207378000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Capital Lease Obligations: 3499960000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Capital Stock: 3274000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Cash And Cash Equivalents: 3783413000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Cash Cash Equivalents And Short Term Investments: 3783413000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Cash Dividends Paid: -133300000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Financing Activities: -1149809000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Investing Activities: -207378000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Operating Activities: 409715000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Change In Account Payable: 67182000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Change In Income Tax Payable: 139086000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Change In Inventory: -225336000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Change In Other Current Assets: -58426000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Change In Other Current Liabilities: -173946000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Change In Other Working Capital: 4463000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Change In Payable: 206268000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Change In Payables And Accrued Expense: 206268000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Change In Tax Payable: 139086000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Change In Working Capital: -246977000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Changes In Cash: -947472000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Common Stock: 3274000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Common Stock Dividend Paid: -133300000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Common Stock Equity: 5576078000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Common Stock Payments: -322652000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Construction In Progress: 864381000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Cost Of Revenue: 3581366000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Current Accrued Expenses: 890885000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Current Assets: 6875103000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Current Capital Lease Obligation: 702025000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Current Debt: 498812000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Current Debt And Capital Lease Obligation: 1200837000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Current Liabilities: 4435759000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Deferred Income Tax: 22209000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Deferred Tax: 22209000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Depreciation Amortization Depletion: 115938000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Depreciation And Amortization: 115938000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Diluted Average Shares: 327005000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Diluted EPS: 1.47
RSO.DE income_statement (quarterly, 2025-04-30) — Diluted NI Availto Com Stockholders: 479249000.00
RSO.DE income_statement (quarterly, 2025-04-30) — EBIT: 653338000.00
RSO.DE income_statement (quarterly, 2025-04-30) — EBITDA: 769276000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — End Cash Position: 3848990000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Financing Cash Flow: -1149809000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Finished Goods: 2669849000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Free Cash Flow: 202337000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Gross PPE: 11965502000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Gross Profit: 1403605000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Income Tax Paid Supplemental Data: 334000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Income Tax Payable: 180083000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Interest Expense: 12459000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Interest Expense Non Operating: 12459000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Interest Income: 46868000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Interest Income Non Operating: 46868000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Interest Paid Supplemental Data: 35939000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Inventory: 2669849000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Invested Capital: 7091787000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Investing Cash Flow: -207378000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Land And Improvements: 1494018000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Leases: 1719361000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Long Term Capital Lease Obligation: 2797935000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Long Term Debt: 1016897000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Long Term Debt And Capital Lease Obligation: 3814832000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Long Term Debt Payments: -700000000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Machinery Furniture Equipment: 4561893000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Net Common Stock Issuance: -322652000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Net Income: 479249000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Net Income Common Stockholders: 479249000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Net Income Continuous Operations: 479249000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Net Income From Continuing And Discontinued Operation: 479249000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Net Income From Continuing Operation Net Minority Interest: 479249000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Net Income From Continuing Operations: 479249000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Net Income Including Noncontrolling Interests: 479249000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Net Interest Income: 34409000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Net Issuance Payments Of Debt: -700000000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Net Long Term Debt Issuance: -700000000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Net Non Operating Interest Income Expense: 34409000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Net PPE: 7153390000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Net PPE Purchase And Sale: -207378000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Net Tangible Assets: 5576078000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Liabilities: 209249000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Taxes Liabilities: 209249000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Normalized EBITDA: 769276000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Normalized Income: 479249000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Operating Cash Flow: 409715000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Operating Income: 606470000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Operating Revenue: 4984971000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Ordinary Shares Number: 327384000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Other Current Assets: 240837000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Other Current Borrowings: 498812000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Other Non Current Assets: 276123000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Other Non Current Liabilities: 268698000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Other Properties: 3325849000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Payables: 2344037000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Payables And Accrued Expenses: 3234922000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Pretax Income: 640879000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Proceeds From Stock Option Exercised: 6143000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Properties: 0.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Purchase Of PPE: -207378000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Receivables: 181004000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Reconciled Cost Of Revenue: 3581366000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Reconciled Depreciation: 115938000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Repayment Of Debt: -700000000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Repurchase Of Capital Stock: -322652000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Retained Earnings: 4220812000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Selling General And Administration: 797135000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Share Issued: 327384000.00
RSO.DE cash_flow (quarterly, 2025-04-30) — Stock Based Compensation: 39296000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Stockholders Equity: 5576078000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Tangible Book Value: 5576078000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Tax Effect Of Unusual Items: 0.00
RSO.DE income_statement (quarterly, 2025-04-30) — Tax Provision: 161630000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Tax Rate For Calcs: 0.25
RSO.DE balance_sheet (quarterly, 2025-04-30) — Total Assets: 14304616000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Total Capitalization: 6592975000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Total Debt: 5015669000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Total Equity Gross Minority Interest: 5576078000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Total Expenses: 4378501000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Total Liabilities Net Minority Interest: 8728538000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Total Non Current Assets: 7429513000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Total Non Current Liabilities Net Minority Interest: 4292779000.00
RSO.DE income_statement (quarterly, 2025-04-30) — Total Operating Income As Reported: 606470000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Total Tax Payable: 180083000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Treasury Stock: 779541000.00
RSO.DE balance_sheet (quarterly, 2025-04-30) — Working Capital: 2439344000.00
RSO.DE income_statement (quarterly, 2025-07-31) — +Operating Expense: 888711000.00
RSO.DE income_statement (quarterly, 2025-07-31) — +Total Revenue: 5529152000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Accounts Payable: 2205613000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Accounts Receivable: 210520000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Accumulated Depreciation: -4920714000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Additional Paid In Capital: 2170734000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Basic Average Shares: 323000000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Basic EPS: 1.57
RSO.DE cash_flow (quarterly, 2025-07-31) — Beginning Cash Position: 3848990000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Capital Expenditure: -201727000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Capital Lease Obligations: 3551643000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Capital Stock: 3255000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Cash And Cash Equivalents: 3847016000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Cash Cash Equivalents And Short Term Investments: 3847016000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Cash Dividends Paid: -132337000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Financing Activities: -402332000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Investing Activities: -201727000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Operating Activities: 668362000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Change In Account Payable: 34755000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Change In Income Tax Payable: -193225000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Change In Inventory: 61364000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Change In Other Current Assets: -33623000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Change In Other Current Liabilities: 90811000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Change In Other Working Capital: 207000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Change In Payable: -158470000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Change In Payables And Accrued Expense: -158470000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Change In Tax Payable: -193225000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Change In Working Capital: -39711000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Changes In Cash: 64303000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Common Stock: 3255000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Common Stock Dividend Paid: -132337000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Common Stock Equity: 5732569000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Common Stock Payments: -266789000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Construction In Progress: 394493000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Cost Of Revenue: 4002167000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Current Accrued Expenses: 971111000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Current Assets: 6925836000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Current Capital Lease Obligation: 716162000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Current Debt: 499122000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Current Debt And Capital Lease Obligation: 1215284000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Current Liabilities: 4392008000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Deferred Income Tax: 29736000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Deferred Tax: 29736000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Depreciation Amortization Depletion: 126399000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Depreciation And Amortization: 126399000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Diluted Average Shares: 324796000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Diluted EPS: 1.56
RSO.DE income_statement (quarterly, 2025-07-31) — Diluted NI Availto Com Stockholders: 507995000.00
RSO.DE income_statement (quarterly, 2025-07-31) — EBIT: 678600000.00
RSO.DE income_statement (quarterly, 2025-07-31) — EBITDA: 804999000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — End Cash Position: 3913293000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Financing Cash Flow: -402332000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Finished Goods: 2608485000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Free Cash Flow: 466635000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Gross PPE: 12201636000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Gross Profit: 1526985000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Income Tax Paid Supplemental Data: 326115000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Income Tax Payable: 0.00
RSO.DE income_statement (quarterly, 2025-07-31) — Interest Expense: 7980000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Interest Expense Non Operating: 7980000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Interest Income: 40326000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Interest Income Non Operating: 40326000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Interest Paid Supplemental Data: 0.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Inventory: 2608485000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Invested Capital: 7248909000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Investing Cash Flow: -201727000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Land And Improvements: 1821855000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Leases: 1727314000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Long Term Capital Lease Obligation: 2835481000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Long Term Debt: 1017218000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Long Term Debt And Capital Lease Obligation: 3852699000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Long Term Debt Payments: 0.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Machinery Furniture Equipment: 4883392000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Net Common Stock Issuance: -266789000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Net Income: 507995000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Net Income Common Stockholders: 507995000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Net Income Continuous Operations: 507995000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Net Income From Continuing And Discontinued Operation: 507995000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Net Income From Continuing Operation Net Minority Interest: 507995000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Net Income From Continuing Operations: 507995000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Net Income Including Noncontrolling Interests: 507995000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Net Interest Income: 32346000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Net Issuance Payments Of Debt: 0.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Net Long Term Debt Issuance: 0.00
RSO.DE income_statement (quarterly, 2025-07-31) — Net Non Operating Interest Income Expense: 32346000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Net PPE: 7280922000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Net PPE Purchase And Sale: -201727000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Net Tangible Assets: 5732569000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Liabilities: 238985000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Taxes Liabilities: 238985000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Normalized EBITDA: 804999000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Normalized Income: 507995000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Operating Cash Flow: 668362000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Operating Income: 638274000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Operating Revenue: 5529152000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Ordinary Shares Number: 325531000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Other Current Assets: 259815000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Other Current Borrowings: 499122000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Other Non Current Assets: 288761000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Other Non Current Liabilities: 279258000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Other Properties: 3374582000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Payables: 2205613000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Payables And Accrued Expenses: 3176724000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Pretax Income: 670620000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Proceeds From Stock Option Exercised: 6237000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Properties: 0.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Purchase Of PPE: -201727000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Receivables: 210520000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Reconciled Cost Of Revenue: 4002167000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Reconciled Depreciation: 126399000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Repayment Of Debt: 0.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Repurchase Of Capital Stock: -266789000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Retained Earnings: 4342410000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Selling General And Administration: 888711000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Share Issued: 325531000.00
RSO.DE cash_flow (quarterly, 2025-07-31) — Stock Based Compensation: 43943000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Stockholders Equity: 5732569000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Tangible Book Value: 5732569000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Tax Effect Of Unusual Items: 0.00
RSO.DE income_statement (quarterly, 2025-07-31) — Tax Provision: 162625000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Tax Rate For Calcs: 0.24
RSO.DE balance_sheet (quarterly, 2025-07-31) — Total Assets: 14495519000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Total Capitalization: 6749787000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Total Debt: 5067983000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Total Equity Gross Minority Interest: 5732569000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Total Expenses: 4890878000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Total Liabilities Net Minority Interest: 8762950000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Total Non Current Assets: 7569683000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Total Non Current Liabilities Net Minority Interest: 4370942000.00
RSO.DE income_statement (quarterly, 2025-07-31) — Total Operating Income As Reported: 638274000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Total Tax Payable: 0.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Treasury Stock: 783830000.00
RSO.DE balance_sheet (quarterly, 2025-07-31) — Working Capital: 2533828000.00
RSO.DE income_statement (quarterly, 2025-10-31) — +Operating Expense: 920002000.00
RSO.DE income_statement (quarterly, 2025-10-31) — +Total Revenue: 5600946000.00
RSO.DE balance_sheet (quarterly, 2025-10-31) — Accounts Payable: 2645234000.00
RSO.DE balance_sheet (quarterly, 2025-10-31) — Accounts Receivable: 203891000.00
RSO.DE balance_sheet (quarterly, 2025-10-31) — Accumulated Depreciation: -5024667000.00
RSO.DE balance_sheet (quarterly, 2025-10-31) — Additional Paid In Capital: 2212220000.00
RSO.DE income_statement (quarterly, 2025-10-31) — Basic Average Shares: 321270000.00
RSO.DE income_statement (quarterly, 2025-10-31) — Basic EPS: 1.59
RSO.DE cash_flow (quarterly, 2025-10-31) — Beginning Cash Position: 3913293000.00
RSO.DE cash_flow (quarterly, 2025-10-31) — Capital Expenditure: -209261000.00
RSO.DE balance_sheet (quarterly, 2025-10-31) — Capital Lease Obligations: 3671617000.00
RSO.DE balance_sheet (quarterly, 2025-10-31) — Capital Stock: 3237000.00
RSO.DE balance_sheet (quarterly, 2025-10-31) — Cash And Cash Equivalents: 4061173000.00
RSO.DE balance_sheet (quarterly, 2025-10-31) — Cash Cash Equivalents And Short Term Investments: 4061173000.00
RSO.DE cash_flow (quarterly, 2025-10-31) — Cash Dividends Paid: -131557000.00
RSO.DE cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Financing Activities: -402985000.00
RSO.DE cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Investing Activities: -209261000.00
RSO.DE cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Operating Activities: 827088000.00
RSO.DE cash_flow (quarterly, 2025-10-31) — Change In Account Payable: 435622000.00
RSO.DE cash_flow (quarterly, 2025-10-31) — Change In Income Tax Payable: 42869000.00